Filing Details
- Accession Number:
- 0001213900-22-027983
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-18 17:21:07
- Reporting Period:
- 2022-05-17
- Accepted Time:
- 2022-05-18 17:21:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1410098 | Cormedix Inc. | CRMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1672645 | Myron Kaplan | C/O Cormedix Inc. 300 Connell Drive, 300 Connell Drive, Suite 4200 Berkeley Heights NJ 07922 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-17 | 5,000 | $3.78 | 160,034 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 20,000 | Indirect | Spouse |
Common Stock | 10,000 | Indirect | Spouse as Guardian for Grandchildren |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy Common Stock) | $4.03 | 2032-02-22 | 20,000 | 20,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $8.32 | 2031-01-11 | 30,000 | 30,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $5.63 | 2030-02-25 | 15,000 | 15,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $8.30 | 2029-01-10 | 15,000 | 15,000 | Direct | |
Common Stock | Stock Option (Right to(Right to Buy Common Stock) | $2.85 | 2028-02-16 | 8,000 | 8,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $11.20 | 2027-02-21 | 8,000 | 8,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $21.40 | 2026-04-28 | 10,000 | 1,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2032-02-22 | 20,000 | 20,000 | Direct |
2031-01-11 | 30,000 | 30,000 | Direct |
2030-02-25 | 15,000 | 15,000 | Direct |
2029-01-10 | 15,000 | 15,000 | Direct |
2028-02-16 | 8,000 | 8,000 | Direct |
2027-02-21 | 8,000 | 8,000 | Direct |
2026-04-28 | 10,000 | 1,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.79,inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and ExchangeCommission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote tothis Form 4.
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is thebeneficial owner of the securities for purposes of Section 16 or for any other purpose.
- These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continuedservice on the board.
- These options were granted on 1/11/2021. These options are fully vested.
- These options were granted on 2/25/2020. These options are fully vested.
- These options were granted on 1/10/2019. These options are fully vested.
- These options were granted on 2/16/2018. These options are fully vested.
- These options were granted on 2/21/2017. These options are fully vested.
- These options were granted on 4/28/2016. These options are fully vested.